nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Apraclonidine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Apraclonidine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Apraclonidine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Apraclonidine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Apraclonidine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Apraclonidine—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Apraclonidine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Apraclonidine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Apraclonidine—Infection—Vincristine—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Apraclonidine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Apraclonidine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Apraclonidine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Apraclonidine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Apraclonidine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Apraclonidine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Apraclonidine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Apraclonidine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Apraclonidine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Apraclonidine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Apraclonidine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Apraclonidine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Apraclonidine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Apraclonidine—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Apraclonidine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Apraclonidine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Apraclonidine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Apraclonidine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Apraclonidine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Apraclonidine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Apraclonidine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Apraclonidine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Apraclonidine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Apraclonidine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Apraclonidine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Apraclonidine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Apraclonidine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Apraclonidine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Apraclonidine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Apraclonidine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Apraclonidine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Apraclonidine—Malaise—Etoposide—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Apraclonidine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Apraclonidine—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Apraclonidine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Apraclonidine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Apraclonidine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Apraclonidine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Apraclonidine—Infection—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Apraclonidine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Apraclonidine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Apraclonidine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Apraclonidine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Apraclonidine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Apraclonidine—Headache—Topotecan—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Apraclonidine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Apraclonidine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Apraclonidine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Apraclonidine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Apraclonidine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Apraclonidine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Apraclonidine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Apraclonidine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Apraclonidine—Pain—Vincristine—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Apraclonidine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Apraclonidine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Apraclonidine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Apraclonidine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Apraclonidine—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Apraclonidine—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Apraclonidine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Apraclonidine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Apraclonidine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Apraclonidine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Apraclonidine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Apraclonidine—Infection—Etoposide—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Apraclonidine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Apraclonidine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Apraclonidine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Apraclonidine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Apraclonidine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Apraclonidine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Apraclonidine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Apraclonidine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Apraclonidine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Apraclonidine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Apraclonidine—Pain—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Apraclonidine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Apraclonidine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Apraclonidine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Apraclonidine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000997	0.000997	CcSEcCtD
Apraclonidine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00099	0.00099	CcSEcCtD
Apraclonidine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000988	0.000988	CcSEcCtD
Apraclonidine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000981	0.000981	CcSEcCtD
Apraclonidine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000978	0.000978	CcSEcCtD
Apraclonidine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000974	0.000974	CcSEcCtD
Apraclonidine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000967	0.000967	CcSEcCtD
Apraclonidine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000967	0.000967	CcSEcCtD
Apraclonidine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000967	0.000967	CcSEcCtD
Apraclonidine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000964	0.000964	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00095	0.00095	CcSEcCtD
Apraclonidine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000949	0.000949	CcSEcCtD
Apraclonidine—Pain—Etoposide—peripheral nervous system neoplasm	0.000941	0.000941	CcSEcCtD
Apraclonidine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000941	0.000941	CcSEcCtD
Apraclonidine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00094	0.00094	CcSEcCtD
Apraclonidine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000932	0.000932	CcSEcCtD
Apraclonidine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000929	0.000929	CcSEcCtD
Apraclonidine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000907	0.000907	CcSEcCtD
Apraclonidine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000903	0.000903	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.0009	0.0009	CcSEcCtD
Apraclonidine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000898	0.000898	CcSEcCtD
Apraclonidine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000896	0.000896	CcSEcCtD
Apraclonidine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000895	0.000895	CcSEcCtD
Apraclonidine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000895	0.000895	CcSEcCtD
Apraclonidine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000888	0.000888	CcSEcCtD
Apraclonidine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000885	0.000885	CcSEcCtD
Apraclonidine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000884	0.000884	CcSEcCtD
Apraclonidine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000883	0.000883	CcSEcCtD
Apraclonidine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00087	0.00087	CcSEcCtD
Apraclonidine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00087	0.00087	CcSEcCtD
Apraclonidine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00087	0.00087	CcSEcCtD
Apraclonidine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000868	0.000868	CcSEcCtD
Apraclonidine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000864	0.000864	CcSEcCtD
Apraclonidine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000862	0.000862	CcSEcCtD
Apraclonidine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000862	0.000862	CcSEcCtD
Apraclonidine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000856	0.000856	CcSEcCtD
Apraclonidine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000855	0.000855	CcSEcCtD
Apraclonidine—Headache—Vincristine—peripheral nervous system neoplasm	0.000851	0.000851	CcSEcCtD
Apraclonidine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000837	0.000837	CcSEcCtD
Apraclonidine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000837	0.000837	CcSEcCtD
Apraclonidine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000822	0.000822	CcSEcCtD
Apraclonidine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000818	0.000818	CcSEcCtD
Apraclonidine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000811	0.000811	CcSEcCtD
Apraclonidine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000811	0.000811	CcSEcCtD
Apraclonidine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000807	0.000807	CcSEcCtD
Apraclonidine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000805	0.000805	CcSEcCtD
Apraclonidine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000803	0.000803	CcSEcCtD
Apraclonidine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000797	0.000797	CcSEcCtD
Apraclonidine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000791	0.000791	CcSEcCtD
Apraclonidine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000789	0.000789	CcSEcCtD
Apraclonidine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000788	0.000788	CcSEcCtD
Apraclonidine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000782	0.000782	CcSEcCtD
Apraclonidine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000778	0.000778	CcSEcCtD
Apraclonidine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000775	0.000775	CcSEcCtD
Apraclonidine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000774	0.000774	CcSEcCtD
Apraclonidine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000764	0.000764	CcSEcCtD
Apraclonidine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000761	0.000761	CcSEcCtD
Apraclonidine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000757	0.000757	CcSEcCtD
Apraclonidine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000756	0.000756	CcSEcCtD
Apraclonidine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000753	0.000753	CcSEcCtD
Apraclonidine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000751	0.000751	CcSEcCtD
Apraclonidine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000742	0.000742	CcSEcCtD
Apraclonidine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00074	0.00074	CcSEcCtD
Apraclonidine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000734	0.000734	CcSEcCtD
Apraclonidine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000729	0.000729	CcSEcCtD
Apraclonidine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000728	0.000728	CcSEcCtD
Apraclonidine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000724	0.000724	CcSEcCtD
Apraclonidine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000718	0.000718	CcSEcCtD
Apraclonidine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000713	0.000713	CcSEcCtD
Apraclonidine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000712	0.000712	CcSEcCtD
Apraclonidine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000704	0.000704	CcSEcCtD
Apraclonidine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000701	0.000701	CcSEcCtD
Apraclonidine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.0007	0.0007	CcSEcCtD
Apraclonidine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000699	0.000699	CcSEcCtD
Apraclonidine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000693	0.000693	CcSEcCtD
Apraclonidine—Headache—Etoposide—peripheral nervous system neoplasm	0.000689	0.000689	CcSEcCtD
Apraclonidine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000686	0.000686	CcSEcCtD
Apraclonidine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000685	0.000685	CcSEcCtD
Apraclonidine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000681	0.000681	CcSEcCtD
Apraclonidine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000679	0.000679	CcSEcCtD
Apraclonidine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000678	0.000678	CcSEcCtD
Apraclonidine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000668	0.000668	CcSEcCtD
Apraclonidine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000659	CcSEcCtD
Apraclonidine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000654	0.000654	CcSEcCtD
Apraclonidine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000649	0.000649	CcSEcCtD
Apraclonidine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000643	0.000643	CcSEcCtD
Apraclonidine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000643	0.000643	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Apraclonidine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000636	0.000636	CcSEcCtD
Apraclonidine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000631	0.000631	CcSEcCtD
Apraclonidine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000629	0.000629	CcSEcCtD
Apraclonidine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000627	0.000627	CcSEcCtD
Apraclonidine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000618	0.000618	CcSEcCtD
Apraclonidine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000617	0.000617	CcSEcCtD
Apraclonidine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000613	0.000613	CcSEcCtD
Apraclonidine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000605	0.000605	CcSEcCtD
Apraclonidine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000599	0.000599	CcSEcCtD
Apraclonidine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000595	0.000595	CcSEcCtD
Apraclonidine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000595	0.000595	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.000591	CcSEcCtD
Apraclonidine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.000588	CcSEcCtD
Apraclonidine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.000582	CcSEcCtD
Apraclonidine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.000571	CcSEcCtD
Apraclonidine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000567	0.000567	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000562	CcSEcCtD
Apraclonidine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.00056	CcSEcCtD
Apraclonidine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000558	0.000558	CcSEcCtD
Apraclonidine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Apraclonidine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Apraclonidine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00055	0.00055	CcSEcCtD
Apraclonidine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000548	0.000548	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Apraclonidine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Apraclonidine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000527	0.000527	CcSEcCtD
Apraclonidine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000527	0.000527	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.00052	CcSEcCtD
Apraclonidine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Apraclonidine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.000512	CcSEcCtD
Apraclonidine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.000509	CcSEcCtD
Apraclonidine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000508	CcSEcCtD
Apraclonidine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000504	0.000504	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000493	0.000493	CcSEcCtD
Apraclonidine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000492	CcSEcCtD
Apraclonidine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.000488	CcSEcCtD
Apraclonidine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.000488	CcSEcCtD
Apraclonidine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000488	0.000488	CcSEcCtD
Apraclonidine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.000467	CcSEcCtD
Apraclonidine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Apraclonidine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000451	0.000451	CcSEcCtD
Apraclonidine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Apraclonidine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Apraclonidine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000422	CcSEcCtD
Apraclonidine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Apraclonidine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000409	CcSEcCtD
Apraclonidine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Apraclonidine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Apraclonidine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Apraclonidine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Apraclonidine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Apraclonidine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Apraclonidine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000377	CcSEcCtD
Apraclonidine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000366	CcSEcCtD
Apraclonidine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000363	CcSEcCtD
Apraclonidine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Apraclonidine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Apraclonidine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000339	CcSEcCtD
